Sponsor Pipeline

Dizal (Jiangsu) Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07182682 A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With… Non-Small Cell Lung Cancer Recruiting
Phase 1/2
NCT07079475 Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have… Non-Small Cell Lung Cancer Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2)
Get alerts when Dizal (Jiangsu) Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free